rs704243

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_138761.4(BAX):​c.*78G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.894 in 1,067,090 control chromosomes in the GnomAD database, including 428,073 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.89 ( 59164 hom., cov: 23)
Exomes 𝑓: 0.89 ( 368909 hom. )

Consequence

BAX
NM_138761.4 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.398

Publications

16 publications found
Variant links:
Genes affected
BAX (HGNC:959): (BCL2 associated X, apoptosis regulator) The protein encoded by this gene belongs to the BCL2 protein family. BCL2 family members form hetero- or homodimers and act as anti- or pro-apoptotic regulators that are involved in a wide variety of cellular activities. This protein forms a heterodimer with BCL2, and functions as an apoptotic activator. The association and the ratio of BAX to BCL2 also determines survival or death of a cell following an apoptotic stimulus. This protein is reported to interact with, and increase the opening of, the mitochondrial voltage-dependent anion channel (VDAC), which leads to the loss in membrane potential and the release of cytochrome c. The expression of this gene is regulated by the tumor suppressor P53 and has been shown to be involved in P53-mediated apoptosis. Multiple alternatively spliced transcript variants, which encode different isoforms, have been reported for this gene. [provided by RefSeq, Dec 2019]
BAX Gene-Disease associations (from GenCC):
  • leukemia, acute lymphocytic, susceptibility to, 1
    Inheritance: Unknown Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.72).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.914 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BAXNM_138761.4 linkc.*78G>A 3_prime_UTR_variant Exon 6 of 6 ENST00000345358.12 NP_620116.1 Q07812-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BAXENST00000345358.12 linkc.*78G>A 3_prime_UTR_variant Exon 6 of 6 1 NM_138761.4 ENSP00000263262.9 Q07812-1

Frequencies

GnomAD3 genomes
AF:
0.889
AC:
132878
AN:
149496
Hom.:
59118
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.894
Gnomad AMI
AF:
0.856
Gnomad AMR
AF:
0.853
Gnomad ASJ
AF:
0.918
Gnomad EAS
AF:
0.932
Gnomad SAS
AF:
0.937
Gnomad FIN
AF:
0.903
Gnomad MID
AF:
0.904
Gnomad NFE
AF:
0.884
Gnomad OTH
AF:
0.877
GnomAD4 exome
AF:
0.895
AC:
820996
AN:
917478
Hom.:
368909
Cov.:
12
AF XY:
0.897
AC XY:
416464
AN XY:
464466
show subpopulations
African (AFR)
AF:
0.892
AC:
18321
AN:
20542
American (AMR)
AF:
0.836
AC:
22862
AN:
27342
Ashkenazi Jewish (ASJ)
AF:
0.923
AC:
18533
AN:
20086
East Asian (EAS)
AF:
0.951
AC:
28890
AN:
30376
South Asian (SAS)
AF:
0.935
AC:
62849
AN:
67184
European-Finnish (FIN)
AF:
0.909
AC:
33820
AN:
37206
Middle Eastern (MID)
AF:
0.905
AC:
4068
AN:
4494
European-Non Finnish (NFE)
AF:
0.889
AC:
595704
AN:
670044
Other (OTH)
AF:
0.894
AC:
35949
AN:
40204
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
3789
7578
11368
15157
18946
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11194
22388
33582
44776
55970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.889
AC:
132980
AN:
149612
Hom.:
59164
Cov.:
23
AF XY:
0.890
AC XY:
64915
AN XY:
72942
show subpopulations
African (AFR)
AF:
0.894
AC:
36171
AN:
40480
American (AMR)
AF:
0.854
AC:
12792
AN:
14982
Ashkenazi Jewish (ASJ)
AF:
0.918
AC:
3176
AN:
3458
East Asian (EAS)
AF:
0.932
AC:
4623
AN:
4958
South Asian (SAS)
AF:
0.937
AC:
4400
AN:
4696
European-Finnish (FIN)
AF:
0.903
AC:
9273
AN:
10270
Middle Eastern (MID)
AF:
0.911
AC:
266
AN:
292
European-Non Finnish (NFE)
AF:
0.884
AC:
59709
AN:
67524
Other (OTH)
AF:
0.877
AC:
1796
AN:
2048
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
672
1344
2015
2687
3359
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
886
1772
2658
3544
4430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.885
Hom.:
22417
Bravo
AF:
0.884

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.72
CADD
Benign
7.5
DANN
Benign
0.89
PhyloP100
-0.40
RBP_binding_hub_radar
0.92
RBP_regulation_power_radar
2.0
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs704243; hg19: chr19-49464971; COSMIC: COSV53170523; COSMIC: COSV53170523; API